Changing clinical and pathological features of gastric cancer over time

被引:66
作者
Marrelli, D. [1 ]
Pedrazzani, C.
Morgagni, P. [2 ]
de Manzoni, G. [4 ]
Pacelli, F. [6 ]
Coniglio, A. [5 ]
Marchet, A. [7 ]
Saragoni, L. [3 ]
Giacopuzzi, S. [4 ]
Roviello, F.
机构
[1] Univ Siena, Dept Human Pathol & Oncol, Sect Surg Oncol, Policlin Le Scotte, I-53100 Siena, Italy
[2] Morgagni Hosp, Dept Gen Surg, Forli, Italy
[3] Morgagni Hosp, Dept Pathol, Forli, Italy
[4] Univ Verona, Div Gen Surg, I-37100 Verona, Italy
[5] Univ Brescia, Surg Clin, Brescia, Italy
[6] Catholic Univ, Rome, Italy
[7] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
关键词
D2; LYMPHADENECTOMY; STOMACH-CANCER; UNITED-STATES; DIFFUSE TYPES; RISK-FACTORS; LYMPH-NODES; EXTENDED D2; SURVIVAL; CARCINOMA; SURGERY;
D O I
10.1002/bjs.7528
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The aim of the present multicentre observational study was to evaluate potential changes in clinical and pathological features of patients with gastric cancer (GC) treated in a 15-year interval. Methods: A centralized prospective database including clinical, surgical, pathological and follow-up data from 2822 patients who had resection of a primary GC was analysed. The analysis focused on three periods: 1991-1995 (period 1), 1996-2000 (period 2) and 2001-2005 (period 3). Surgical procedure, pathological classification and follow-up were standardized among centres. Results: The number of resections decreased from 1024 in period 1 to 955 and 843 in periods 2 and 3 respectively. More advanced stages and a smaller number of intestinal-type tumours of the distal third were observed over time. Five-year survival rates after R0 resection (2320 patients) did not change over time (overall: 56.6 and 51.2 per cent in periods 1 and 3; disease-free: 66.8 and 61.1 per cent respectively). Decreases in survival in more recent years were related particularly to more advanced stage, distal tumours and tumours in women. Multivariable analysis showed a lower probability of overall and disease-free survival in the most recent interval: hazard ratio 1.22 (95 per cent confidence interval 1.06 to 1.40) and 1.29 (1.06 to 1.58) respectively compared with period 1. Recurrent tumours were more frequently peritoneal rather than locoregional. Conclusion: Overall and disease-free survival rates after R0 resection of GC were unchanged over time.
引用
收藏
页码:1273 / 1283
页数:11
相关论文
共 37 条
[1]   A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer Patients [J].
Baiocchi, Gian Luca ;
Tiberio, Guido A. ;
Minicozzi, Anna Maria ;
Morgagni, Paolo ;
Marrelli, Daniele ;
Bruno, Lorenzo ;
Rosa, Fausto ;
Marchet, Alberto ;
Coniglio, Arianna ;
Saragoni, Luca ;
Veltri, Marco ;
Pacelli, Fabio ;
Roviello, Franco ;
Nitti, Donato ;
Giulini, Stefano M. ;
De Manzoni, Giovanni .
ANNALS OF SURGERY, 2010, 252 (01) :70-73
[2]   Recent patterns in gastric cancer: A global overview [J].
Bertuccio, Paola ;
Chatenoud, Liliane ;
Levi, Fabio ;
Praud, Delphine ;
Ferlay, Jacques ;
Negri, Eva ;
Malvezzi, Matteo ;
La Vecchia, Carlo .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) :666-673
[3]  
Blok P, 1997, QJM-INT J MED, V90, P735
[4]   Gastric cancer [J].
Catalano, Vincenzo ;
Labianca, Roberto ;
Beretta, Giordano D. ;
Gatta, Gemma ;
De Braud, Filippo ;
Van Cutsem, Eric .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (02) :127-164
[5]   Survival trends in patients with gastric and esophageal adenocarcinomas: A population-based study [J].
Crane, Sarah J. ;
Locke, G. Richard, III ;
Harmsen, William S. ;
Zinsmeister, Alan R. ;
Romero, Yvonne ;
Talley, Nicholas J. .
MAYO CLINIC PROCEEDINGS, 2008, 83 (10) :1087-1094
[6]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[7]   Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands [J].
Dassen, A. E. ;
Lemmens, V. E. P. P. ;
van de Poll-Franse, L. V. ;
Creemers, G. J. ;
Brenninkmeijer, S. J. ;
Lips, D. J. ;
Wurff, A. A. M. Vd ;
Bosscha, K. ;
Coebergh, J. W. W. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (06) :1101-1110
[8]   Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995 [J].
Fayçal, J ;
Bessaguet, C ;
Nousbaum, JB ;
Cauvin, JM ;
Cholet, F ;
Bideau, K ;
Robaszkiewicz, M ;
Gouéron, H .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (01) :23-32
[9]   Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC) [J].
Folli, S ;
Morgagni, P ;
Roviello, F ;
De Manzoni, G ;
Marrelli, D ;
Saragoni, L ;
Di Leo, A ;
Gaudio, M ;
ScD, ON ;
Carli, A ;
Cordiano, C ;
Dell'Amore, D ;
Vio, A .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (10) :495-499
[10]   Survival in stomach cancer is improving -: Results of a nationwide population-based Swedish study [J].
Hansson, LE ;
Sparén, P ;
Nyrén, O .
ANNALS OF SURGERY, 1999, 230 (02) :162-169